Tmd Clinical Trials 2023

Tmd Clinical Trials 2023

Tmd research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in tmd clinical trials today.

Trials for TMJ Patients

Trials for Temporomandibular Joint Disorder Patients

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to tmd

What are the top hospitals conducting tmd research?

When it comes to clinical trials focused on temporomandibular disorders (TMD), several top hospitals are at the forefront of research and innovation. The University of Florida in Gainesville stands out with two active TMD trials, marking their dedication to understanding and treating this condition. While they have only recorded two TMD trials thus far, their involvement began as recently as 2021, showcasing their commitment to exploring new avenues for patients suffering from TMD. UConn Health in Farmington is another notable institution making strides in TMD research with two ongoing clinical trials. Their first recorded trial also took place in 2021, demonstrating a fresh approach to addressing this complex disorder.

In Boston, the Massachusetts Eye and Ear Infirmary has emerged as a leader in tackling TMD through its innovative clinical trial efforts. Though currently conducting just one active trial pertaining to this disorder, the institution's commitment is evident by initiating its inaugural study in 2022. Similarly dedicated is the Indiana University School of Dentistry's Oral Health Research Institute located in Indianapolis, which has one ongoing TMD trial alongside an impressive history of one completed study since launching its first investigation into TMD back in 2021.

Lastly but certainly not least important is Luana Colloca facility based within Baltimore whose importance lies beyond that; even though involved once again solely performing single current tmd-focused experiment while maintaining similar track record when compared against previously mentioned institutions—having initiated exploration processes revolving around these debilitating conditions exclusively starting from year twenty-twenty-one.

These leading hospitals exemplify the collaborative efforts taking place across different regions within our healthcare system to shed light on temporomandibular disorders. By investing time and resources into these vital studies today, we lay the foundation for better diagnosis methods and treatment options tomorrow—ultimately offering hope and relief for individuals living with chronic jaw pain or dysfunction caused by TMD-related issues.

Which are the best cities for tmd clinical trials?

When it comes to TMD clinical trials, several cities have emerged as leaders in research and development. Gainesville, Florida, offers 2 active trials that focus on interventions like Active PBM and the THOR® laser system. Farmington, Connecticut, also boasts 2 ongoing studies investigating innovative approaches such as the painTRAINER pain management web application and an Individualized Assessment and Treatment Program. Lastly, Boston, Massachusetts; Indianapolis, Indiana; and Baltimore, Maryland each have 1 active trial exploring different aspects of TMD diagnosis and treatment. These cities provide individuals with opportunities to participate in cutting-edge clinical trials aimed at improving our understanding of TMD and developing more effective treatments.

Which are the top treatments for tmd being explored in clinical trials?

In the realm of Temporomandibular Disorders (TMD), one treatment stands out in ongoing clinical trials: DystoniaNet-based diagnosis of isolated dystonia. This innovative approach is currently being tested in one active trial, marking its first appearance in TMD research listings in 2022. While it may be early days for this particular treatment, its potential impact on TMD patients holds promise and warrants further investigation. As researchers delve deeper into understanding TMD, advancements like DystoniaNet-based diagnosis offer hope for improved diagnostics and management strategies to alleviate the burden of this condition.

What are the most recent clinical trials for tmd?

Recent clinical trials have brought promising developments in the field of temporomandibular disorder (TMD) treatment. Arm A, a Phase 2 trial, has shown potential benefits for individuals with TMD. Additionally, the Natural History study, which encompasses both Phase 1 and Phase 2, aims to better understand the progression and outcomes of TMD. Another notable trial investigated the effectiveness of the THOR® laser system as a therapeutic intervention for TMD. These studies offer hope for improved management and relief for those affected by this condition.

What tmd clinical trials were recently completed?

A recent clinical trial investigating the potential of Botulinum toxin type A in treating temporomandibular disorder (TMD) was successfully completed in August 2018. Sponsored by Weill Medical College of Cornell University, this study has provided valuable insights into the effectiveness and safety of this treatment approach for TMD patients. While more research is needed to fully understand its benefits, these findings offer a promising avenue for addressing the challenges faced by individuals with TMD.